A ‘Catch Up’ Plan for radiotherapy in New South Wales to 2012

In New South Wales (NSW) from 1996 to 2006, only 34–37% of newly diagnosed cancer patients were treated with radiotherapy instead of the 50% proposed by NSW Health in Radiotherapy Plans released in 1991, 1995 and 2003. As a consequence, over 50 000 cancer patients were not treated and has resulted in the estimated premature death of over 8000 patients and over 40 000 years of life lost. In 2008, there were 42 linear accelerators in NSW rather than the 62 recommended. Based on cancer incidence projections, NSW will require 69 linear accelerators in 2012 – a shortfall of 27 linear accelerators. Already 15 linear accelerators have been approved. NSW Health has funding for seven extra linear accelerators, and eight extra linear accelerators are to be funded by the private sector. To make up the shortfall, a ‘Catch Up’ Plan is proposed for an additional 12 linear accelerators by the end of fiscal year 2012. This is estimated to cost $200 million over 4 years for one‐off establishment costs for buildings and equipment plus $50 million per year for recurrent operating costs such as staff salaries. The ‘Catch Up’ Plan will create five new departments of radiation oncology in country hospitals and three new departments in metropolitan hospitals. These will be in addition to those already approved by NSW Health and will markedly improve access for treatment and result in an improvement in cancer survival. This significant increase in departments and equipment can only be achieved by the creation of an NSW Radiotherapy Taskforce similar to that proposed in the Baume report of 2002, ‘A vision for radiotherapy’. Even if the ‘Catch Up’ Plan bridges the gap in service provision, forward planning beyond 2012 should commence immediately as 76 linear accelerators will be required for NSW in 2015 and 81 linear accelerators in 2017.

[1]  Christian Kirisits,et al.  Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  C. Nutting,et al.  Clinical use of intensity-modulated radiotherapy: part II. , 2004, The British journal of radiology.

[3]  D Feldman-Stewart,et al.  Does a centralized radiotherapy system provide adequate access to care? , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Barton,et al.  Radiotherapy utilization in New South Wales from 1996 to 1998. , 2000, Australasian radiology.

[5]  A. Parikh,et al.  Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer. , 2009, Archives of surgery.

[6]  J W Denham,et al.  How do we bring an acceptable level of radiotherapy services to a dispersed population? , 1995, Australasian radiology.

[7]  M. Coates,et al.  Cancer in New South Wales: Incidence and mortality 1997. , 2001, New South Wales public health bulletin.

[8]  S. Fosså,et al.  Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial , 2009, The Lancet.

[9]  T. Whelan,et al.  More evidence that locoregional radiation therapy improves survival: what should we do? , 2005, Journal of the National Cancer Institute.

[10]  Is rural radiation oncology practice quality as good as the big smoke? Results of the Australian radiotherapy single machine unit trial. , 2007, Australasian radiology.

[11]  G. Stevens,et al.  Audit in radiation therapy: long-term survival and cost of treatment. , 1997, Australasian radiology.

[12]  Geoff Delaney,et al.  The role of radiotherapy in cancer treatment , 2005, Cancer.

[13]  A. Shiell,et al.  Efficiency considerations in the expansion of radiation therapy services. , 1995, International journal of radiation oncology, biology, physics.

[14]  I. Tannock,et al.  Repopulation of cancer cells during therapy: an important cause of treatment failure , 2005, Nature Reviews Cancer.

[15]  Radiotherapy service delivery models for a dispersed patient population. , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

[16]  Geoff Delaney M.B.B.S.,et al.  The role of radiotherapy in cancer treatment , 2005 .

[17]  V. Gebski,et al.  Radiation therapy: are we getting value for money? , 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

[18]  G. Morgan A synopsis of radiation oncology in Australia, with particular reference to New South Wales. , 1998, The Australian and New Zealand journal of surgery.

[19]  C. Nutting,et al.  Clinical use of intensity-modulated radiotherapy: part I. , 2004, The British journal of radiology.

[20]  Bruce K Armstrong,et al.  Remoteness of residence and survival from cancer in New South Wales , 2004, The Medical journal of Australia.

[21]  S. Thomas,et al.  Capacity and demand models for radiotherapy treatment machines. , 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).